At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 370 enrolled
Drug / intervention
Diclofenac sodium active topical patch +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A 12-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of HP-5000 Topical System (Patch) in Subjects With Osteoarthritis Pain of the Knee
In Brief
A Phase 3 clinical trial evaluating Diclofenac sodium active topical patch and Placebo patch for Osteoarthritis Pain of the Knee. Completed, enrolled 370 participants across 10 sites.
Detailed Summary
A 12-week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 study to Evaluate the Efficacy and Safety of HP-5000 in Subjects with Osteoarthritis (OA) Pain of the Knee
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis Pain of the Knee
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
202120222023202420252026
First PostedDec 2020
Enrollment StartDec 2020
Primary CompletionJul 2022
Study CompletionJul 2022
TodayJul 2026
First PostedDec 24, 2020
Enrollment StartDec 29, 2020
Primary CompletionJul 18, 2022
Study CompletionJul 25, 2022
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 5.5 years ago
Interventions
Diclofenac sodium active topical patchdrug
A topical patch with diclofenac sodium as active ingredient was used and evaluated for the treatment of OA pain of the knee.
Placebo patchdrug
A placebo patch without diclofenac sodium was used for the placebo arm.